首页> 外文期刊>American Journal of PharmTech Research >Formulation and Evaluation of Naproxen Sodium pulsatile Tablets for Chrono modulated Drug Delivery
【24h】

Formulation and Evaluation of Naproxen Sodium pulsatile Tablets for Chrono modulated Drug Delivery

机译:萘普生钠控释药物缓释片的研制与评价

获取原文
           

摘要

ABSTRACT The objective of present investigation was to prepare a chrono-modulated drug delivery system for Naproxen sodium to meet chrono pharmacological needs of Arthritis. Press coated tablets is a novel oral pulsatile release drug delivery system in which  the drug is released after certain period of lag time generally due to the erosion of barrier layers. Tablets were prepared by direct compression method. The core tablet was formulated using super-disintegrants like sodium starch glycolate, crosspovidone and crosscarmellose sodium. Whereas, the barrier layer contains polymers like carrageenan gum (Viscarin GP-209), xanthan gum in different concentrations and lactose anhydrous as channeling agent for maintaining lag time. The drug-excipient compatibility was confirmed by using FTIR, predicted that there was no chemical interactions between the drug and excipients. The tablets prepared were evaluated for micromeritic properties. In-vitro drug release studies were carried out using pH 1.2 buffer for initial 2hrs and in pH 7.4 phosphate buffer for remaining 10hrs. All the formulations followed first order release kinetics. From the obtained results it was found that the F9 formulation of immediate release core tablets (10% of Crosspovidone) showed optimized in vitro disintegration time and wetting time respectively. In case of press-coated tablets PCT 8 formulation with hydrophilic polymers 19.2% carrageenan gum, 19.2% xanthan gum and 7.69% lactose anhydrous as channeling agent has shown 6hrs of lag time is considered as optimum formulation and is successful in resisting different RPM pressures for designing into pulsatile delivery for treatment of Arthritis. Keywords: Naproxen Sodium, Pulsatile drug delivery system, lag time, press coated tablets.
机译:摘要本研究的目的是为萘普生钠制备一种按时调制的药物输送系统,以满足关节炎的按时药理需要。压制包衣的片剂是新颖的口服脉动释放药物递送系统,其中药物通常在一定的滞后时间后释放,这通常是由于屏障层的侵蚀。通过直接压片法制备片剂。核心片剂是使用超级崩解剂(如乙醇酸淀粉钠,交叉聚维酮和交叉羧甲基纤维素钠)配制的。阻挡层包含角叉菜胶(Viscarin GP-209),不同浓度的黄原胶和无水乳糖等聚合物,以保持滞后时间。通过使用FTIR确认了药物与赋形剂的相容性,并预测药物与赋形剂之间没有化学相互作用。评价所制备的片剂的微胶束性质。使用pH 1.2缓冲液进行初始2小时,并在pH 7.4磷酸盐缓冲液中进行剩余10小时,进行体外药物释放研究。所有制剂均遵循一级释放动力学。从获得的结果中发现,立即释放核心片剂的F9制剂(10%的Crosspovidone)分别显示了最佳的体外崩解时间和润湿时间。对于含有亲水聚合物19.2%角叉菜胶,19.2%黄原胶和无水乳糖7.69%的PCT 8压片片剂,滞后时间为6小时被认为是最佳制剂,并成功抵抗了不同的RPM压力。设计成脉冲式输送以治疗关节炎。关键词:萘普生钠;脉冲给药系统;滞后时间;压制片剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号